Schedule 13D ownership disclosure

MABVAX THERAPEUTICS HOLDINGS, INC.

Security class unavailable · CUSIP: 55414P504

Event date: 2018-02-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,204,352
Percent of class
4.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-18-001885
Form type
SC 13D
Filer
MABVAX THERAPEUTICS HOLDINGS, INC.
CIK
CIK 1109196
Filed
Feb 12, 2018
Reporting period
Feb 12, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub